Rimonabant Kills Colon Cancer Stem Cells without Inducing Toxicity in Normal Colon Organoids

Colorectal cancer (CRC), like other tumor types, is a highly heterogeneous disease. Within the tumor bulk, intra-tumoral heterogeneity is also ascribable to Cancer Stem Cells (CSCs) subpopulation, characterized by high chemoresistance and the unique ability to retain tumorigenic potential, thus asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiore, Donatella, Ramesh, Prashanthi, Proto, Maria C., Piscopo, Chiara, Franceschelli, Silvia, Anzelmo, Serena, Medema, Jan P., Bifulco, Maurizio, Gazzerro, Patrizia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758598/
https://www.ncbi.nlm.nih.gov/pubmed/29354056
http://dx.doi.org/10.3389/fphar.2017.00949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758598/
https://www.ncbi.nlm.nih.gov/pubmed/29354056
http://dx.doi.org/10.3389/fphar.2017.00949

Ejemplares similares